Research Radioimmunotherapy treatment using 177Lu-DOTA-Rituximab shown to be both safe and feasible for Lymphoma patients A study completed by Dr. Andreas Lohri and colleagues has shown that radioimmunotherapy treatment for…adminSeptember 16, 2013
Press Releases “Same Chances” campaign: Quebeckers ask the minister, Dr Réjean Hébert, to solve the problem World Lymphoma Awareness Day is September 15th. Lymphoma is the fifth most common cancer in…adminSeptember 11, 2013
News Support Through Acts of Kindness and Love When Debbi Simon speaks about the outpouring of love she received from friends, family, and…adminAugust 26, 2013
News Emotional Changes from Diagnosis to Treatment Lymphoma is a disease of the blood but the mind is just as impacted in…adminAugust 26, 2013
News Lymphoma Canada Develops New Patient Support Program Robin McQuillan knows the importance of a support group. She and two others founded, and…adminAugust 26, 2013
News New Patient Advisory Committee Initiative Lymphoma Canada is proud to announce its Patient Advisory Committee initiative. This prospective group will…adminAugust 26, 2013
News Changes to the Lymphoma Canada Scientific Advisory Board We are happy to announce that Lymphoma Canada has selected new members of its Scientific…adminAugust 8, 2013
News IBM Canada’s Employee Charity Fund shines a light on Lymphoma Canada Jeff Penman, an executive with the Financial Services Group at IBM Canada Ltd, decided in…adminJuly 24, 2013
News Shedding Light on Lymphocytes The abnormal function of the CYMC gene is still an enigma waiting to be solved…adminJuly 22, 2013
Research Stanford University Study Shows Improvements in Overall Survival for Follicular Grade 1-2 Lymphoma Patients from 1960-2003 A study recently published by Dr. Daryl Tan and colleagues from Stanford University shows encouraging…adminJuly 10, 2013